Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs) https://kusajili.com:443/Trial/hGDOrKJZH0OT2MyEFKg2yQ%24a-phase-iii-double-blind-randomized-placebo-controlled-multicenter-clinical-trial-to-study-the-safety-tolerability-efficacy-and
I have read and accept the terms of use of the site and the Privacy Policy
Send your message